Publication | Closed Access
[Drug interactions of Hypericum perforatum (St. John's wort) are potentially hazardous].
13
Citations
0
References
2000
Year
Hypericum PerforatumPlant PathologyPharmacotherapyDermatologyPlasma LevelsAdverse EffectsPhytopharmacologyToxicologyTherapeutic Drug MonitoringPharmacologyPhytotoxicitySt. JohnHerbal MedicineForensic ToxicologyHerb-drug InteractionClinical PharmacologyPhytochemistryMedicineHypericum ProductsPharmacokinetics
Hypericum can lower the plasma levels of simultaneously administered drugs by induction of metabolism. Combinations of hypericum products with warfarin, cyclosporin, oral contraceptives, theophylline, fenprocoumon, digoxin and indinavir have led to reported interactions and reduced therapeutic activity. It is therefore not advisable to combine hypericum products with other drugs, especially CYP3A4 and p-glycoprotein substrates. Discontinuing hypericum after protracted use may lead to higher plasma levels of the drugs used simultaneously, with the risk of adverse effects. Registered homeopathic preparations with a dilution of 1 in 10,000 or weaker may be regarded as safe.